Efficacy and Safety of SHR0302, a Highly Selective Janus Kinase 1 Inhibitor, in Patients with Moderate to Severe Atopic Dermatitis: A Phase II Randomized Clinical Trial

Yan Zhao, Jianzhong Zhang, Yangfeng Ding et al.|American Journal of Clinical Dermatology|2021

Cited by 59